Peptides such as BPC-157 and TB-500 are: Not FDA approved for treatment of any disease For research purposes only Intended for use under the supervision of a licensed, peptide-trained provider Only available to current patients All protocols are provided strictly for educational and informational purposes and should not be used without medical guidance
Takes ~5 minutes HIPAA-secure intake Cancel anytime Intranasal glutathione supports oxidative balance without injections.* Convenient for travel and patients who prefer non-injectable delivery.* Dosing set after your Nexa telehealth consult.* Explore how this treatment works, what to expect, and how Nexa Vitality supports your goals
The 2.4 mg weekly maintenance dose is where the phase 3 monotherapy trials showed the strongest results, with an average body weight reduction of 11.8% over 68 weeks
However, it is better to keep spacing between them to be on the safe side
Two different selenium-dependent iodothyronine deiodinases (DIOs type 1 and 2) can deiodinate T 4 , thus increasing circulating T 3 , while a third iodothyronine deiodinase (DIO type 3) can convert both T 3 and T 4 to inactive metabolites ( Figure 3 ) (10, 11)
Mistake 5: Inaccurate Dosing Make sure you've drawn the correct amount
